Tumor necrosis factor alpha inhibits the suppressive effect of regulatory T cells on the hepatitis B virus-specific immune response (Q45401519)

14 December 2017

Tumor necrosis factor alpha inhibits the suppressive effect of regulatory T cells on the hepatitis B virus-specific immune response (English)

1 reference

14 December 2017

1 reference

5

Ernst J Kuipers

1 reference

14 December 2017

6

Harry L A Janssen

1 reference

14 December 2017

2

Andrea M Woltman

1 reference

14 December 2017

3

Paula J Biesta

1 reference

PubMed ID

17654744

14 December 2017

Renate G. van der Molen

series ordinal

7

object named as

Renate G van der Molen

1 reference

14 December 2017

4

Johannes G Kusters

1 reference

14 December 2017

Jeroen N Stoop

1

1 reference

PubMed ID

17654744

14 December 2017

language of work or name

English

0 references

publication date

1 September 2007

1 reference

14 December 2017

1 reference

14 December 2017

46

1 reference

14 December 2017

3

1 reference

14 December 2017

699-705

1 reference

TGF-beta-mediated suppression by CD4+CD25+ T cells is facilitated by CTLA-4 signaling

14 December 2017

1 reference

Cutting edge: human CD4+CD25+ T cells restrain the maturation and antigen-presenting function of dendritic cells.

21 January 2018

1 reference

Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific

21 January 2018

1 reference

Subfulminant hepatitis B after infliximab in Crohn's disease: need for HBV-screening?

21 January 2018

1 reference

Immunology of hepatitis B infection

21 January 2018

1 reference

7 January 2021

Hepatitis B virus immunopathogenesis

1 reference

7 January 2021

Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B.

1 reference

7 January 2021

Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection

1 reference

7 January 2021

Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms

1 reference

7 January 2021

The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection

1 reference

7 January 2021

Translation of immunological knowledge into better treatments of chronic hepatitis B.

1 reference

7 January 2021

Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood

1 reference

7 January 2021

Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood

1 reference

7 January 2021

Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses

1 reference

7 January 2021

Control of regulatory T cell development by the transcription factor Foxp3

1 reference

7 January 2021

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

1 reference

7 January 2021

CD4+ CD25+ regulatory T cells control T helper cell type 1 responses to foreign antigens induced by mature dendritic cells in vivo

1 reference

7 January 2021

Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection.

1 reference

7 January 2021

Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B

1 reference

7 January 2021

Modulation of the CD8+-T-cell response by CD4+ CD25+ regulatory T cells in patients with hepatitis B virus infection

1 reference

7 January 2021

CD4+ CD25+ suppressor T cells: more questions than answers

1 reference

7 January 2021

Noncytolytic control of viral infections by the innate and adaptive immune response

1 reference

7 January 2021

Tumor necrosis factor alpha inhibition of hepatitis B virus replication involves disruption of capsid Integrity through activation of NF-kappaB.

1 reference

7 January 2021

Lack of tumor necrosis factor alpha induces impaired proliferation of hepatitis B virus-specific cytotoxic T lymphocytes

1 reference

7 January 2021

Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function.

1 reference

7 January 2021

Vaccination against hepatitis B in liver transplant recipients: pilot analysis of cellular immune response shows evidence of HBsAg-specific regulatory T cells

1 reference

7 January 2021

Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells

1 reference

7 January 2021

An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection.

1 reference

7 January 2021

Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25– T cells

1 reference

7 January 2021

Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells

1 reference

7 January 2021

Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis

1 reference

7 January 2021

Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy

1 reference

7 January 2021

Cytokine profile of viral and autoimmune chronic active hepatitis

1 reference

7 January 2021

Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B.

1 reference

7 January 2021

TNF-alpha -dependent maturation of local dendritic cells is critical for activating the adaptive immune response to virus infection

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.21761

1 reference

14 December 2017

1 reference

PubMed ID

17654744